BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu S, Uniken Venema WT, Westra HJ, Vich Vila A, Barbieri R, Voskuil MD, Blokzijl T, Jansen BH, Li Y, Daly MJ, Xavier RJ, Dijkstra G, Festen EA, Weersma RK. Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease. Nat Commun 2021;12:1122. [PMID: 33602935 DOI: 10.1038/s41467-021-21458-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoon B, Yun Y, Kim KB, Kim D. Inhibition of immunoproteasome attenuates NLRP3 inflammasome formation in tumor necrosis factor α-stimulated intestinal epithelial cell. Biochemical and Biophysical Research Communications 2022;624:157-63. [DOI: 10.1016/j.bbrc.2022.07.120] [Reference Citation Analysis]
2 Hu S, Bourgonje AR, Gacesa R, Jansen BH, Björk JR, Bangma A, Hidding IJ, van Dullemen HM, Visschedijk MC, Faber KN, Dijkstra G, Harmsen HJM, Festen EAM, Vila AV, Spekhorst LM, Weersma RK. Mucosal host–microbe interactions associate with clinical phenotypes in inflammatory bowel disease.. [DOI: 10.1101/2022.06.04.494807] [Reference Citation Analysis]
3 Talebi M, Talebi M, Farkhondeh T, Samarghandian S. Therapeutic Effects of Resveratrol in Inflammatory Bowel Diseases: Shedding Light on the Role of Cellular and Molecular Pathways. Rev Bras Farmacogn 2022;32:160-173. [DOI: 10.1007/s43450-022-00247-9] [Reference Citation Analysis]
4 Lee C. Towards the Genetic Architecture of Complex Gene Expression Traits: Challenges and Prospects for eQTL Mapping in Humans. Genes 2022;13:235. [DOI: 10.3390/genes13020235] [Reference Citation Analysis]
5 Andreu-sánchez S, Bourgonje AR, Vogl T, Kurilshikov A, Leviatan S, Moreno AJR, Hu S, Sinha T, Vila AV, Klompus S, Kalka IN, de Leeuw K, Arends S, Jonkers I, Withoff S, Brouwer E, Weinberger A, Wijmenga C, Segal E, Weersma RK, Fu J, Zhernakova A, Lifelines cohort study. Genetic, environmental and intrinsic determinants of the human antibody epitope repertoire.. [DOI: 10.1101/2021.12.07.471553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhou C, Zhou H, Zhang F, Hao L, Guo J. Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study. Evid Based Complement Alternat Med 2021;2021:1925718. [PMID: 34539797 DOI: 10.1155/2021/1925718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bourgonje AR, Hu S, Spekhorst LM, Zhernakova DV, Vich Vila A, Li Y, Voskuil MD, van Berkel LA, Bley Folly B, Charrout M, Mahfouz A, Reinders MJT, van Heck JIP, Joosten LAB, Visschedijk MC, van Dullemen HM, Faber KN, Samsom JN, Festen EAM, Dijkstra G, Weersma RK. The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease. J Crohns Colitis 2022;16:414-29. [PMID: 34491321 DOI: 10.1093/ecco-jcc/jjab157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]